Filing Flows

Filing Flows › BioMarin Pharmaceutical (BMRN) › Who owns the stock

Who owns BioMarin Pharmaceutical (BMRN) stock

539 funds reported BioMarin Pharmaceutical (BMRN) shares in their latest 13F filings, worth $11.5B in all. The largest holder is BlackRock ($1.2B). Last quarter 256 funds added to their stakes and 246 cut them.

Largest holders of BMRN (13F)Largest holders of BMRN (13F)BlackRock$1.2BVanguard Group$1.1BDodge & COX$849MPrimecap Management$812MVanguard Capital Management LLC$500MVanguard Portfolio Management LLC$495MState Street$446MViking Global Investors LP$436MVestal Point Capital, LP$345MAQR Capital Management LLC$323M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock20,445,212$1.2Bincrease2026-06-30
Vanguard Group18,127,847$1.1Bdecrease2025-12-31
Dodge & COX14,844,930$849Mincrease2026-06-30
Primecap Management14,190,183$812Mdecrease2026-06-30
Vanguard Capital Management LLC8,743,633$500Mincrease2026-06-30
Vanguard Portfolio Management LLC8,648,678$495Mincrease2026-06-30
State Street7,800,959$446Mincrease2026-06-30
Viking Global Investors LP7,616,563$436Mincrease2026-06-30
Vestal Point Capital, LP6,025,000$345Mincrease2026-06-30
AQR Capital Management LLC5,699,541$323Mdecrease2026-06-30
FMR LLC4,822,893$276Mincrease2026-06-30
Dimensional Fund Advisors LP4,075,714$233Mincrease2026-06-30
Geode Capital Management, LLC3,911,794$224Mincrease2026-06-30
Capital Research Global Investors3,504,387$201Mincrease2026-06-30
Deep Track Capital, LP3,307,481$189Mincrease2026-06-30

BioMarin Pharmaceutical's latest quarter

BioMarin Pharmaceutical, Q3 2026: revenue $1.0B (+32% year over year), operating margin -8.0%, net loss $123M, operating cash flow $188M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most BMRN stock?

By the latest 13F filings: BlackRock ($1.2B); Vanguard Group ($1.1B); Dodge & COX ($849M); Primecap Management ($812M); Vanguard Capital Management LLC ($500M).

What is the short interest in BMRN?

12,050,657 shares were sold short at the 2026-10-15 settlement, 4.58% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.